Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study.
Cann
P A
PA
Middlesbrough General Hospital, UK.
Rovati
L C
LC
Smart
H L
HL
Spiller
R C
RC
Whorwell
P J
PJ
D000284:Administration, Oral; D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000503:physiopathology; D003967:Diarrhea / Q000209:etiology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D010865:Pilot Projects; D011377:Proglumide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*
D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D011377:Proglumide